leishmaniasis
Showing 1 - 25 of 238
Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous Trial in Brasilia (Miltefosine 50mg, Pentoxifylline 400mg, Liposomal
Recruiting
- Leishmaniasis; Brazilian
- Leishmaniasis, Mucocutaneous
- Miltefosine 50mg
- +2 more
-
Brasilia, DF, BrazilHospital Universitario de Brasilia
Sep 13, 2023
Cutaneous Leishmaniasis, American Trial in Presidente Tancredo Neves (Oral tofacitinib, Parenteral meglumine antimoniate)
Not yet recruiting
- Cutaneous Leishmaniasis, American
- Oral tofacitinib
- Parenteral meglumine antimoniate
-
Presidente Tancredo Neves, Bahia, BrazilCorte de Pedra Health Post
Aug 21, 2023
Primary Visceral Leishmaniasis Trial in Gondar (LXE408, sodium stibogluconate, Paromomycin)
Not yet recruiting
- Primary Visceral Leishmaniasis
- LXE408
- +2 more
-
Gondar, EthiopiaUniversity of Gondar
Jul 14, 2023
Cutaneous Leishmaniasis, American Trial in Presidente Tancredo Neves (Sm29 Protein, Schistosoma Mansoni, Pentavalent antimony
Completed
- Cutaneous Leishmaniasis, American
- Sm29 Protein, Schistosoma Mansoni
- Pentavalent antimony (Sbv)
-
Presidente Tancredo Neves, Bahia, BrazilCorte de Pedra Health Post
Aug 17, 2023
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and
Not yet recruiting
- Visceral Leishmaniasis
- Antigen detection Rapid Diagnostic Test prototype
- (no location specified)
Nov 1, 2023
Leishmaniasis, Cutaneous Trial in Gharyan (Intralesional Sodium stibogluconate, Intralesional Cryotherapy, Intralesional
Recruiting
- Leishmaniasis, Cutaneous
- Intralesional Sodium stibogluconate
- +3 more
-
Gharyan, Select Region, Libyan Arab JamahiriyaDermatology department, Gharyan University Hospitals, Medical Co
Jan 31, 2023
Cutaneous Leishmaniasis Diagnostic Study
Active, not recruiting
- Cutaneous Leishmaniases
- Skin slit
- +2 more
-
Gondar, EthiopiaLeishmania Research and Treatment Center, University of Gondar h
Oct 27, 2022
Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
Recruiting
- Leishmaniasis
- +2 more
-
Lankien, Jonglei, South SudanLankien Hospital
Jul 4, 2022
Predicting Visceral Leishmaniasis in HIV Infected Patients
Terminated
- Leishmaniasis, Visceral
- No intervention
-
Abderafi, Amhara, EthiopiaAbdurafi Health Center
Sep 6, 2022
Clinical Prognostic Score to Predict Relapse in VL
Not yet recruiting
- Visceral Leishmaniasis
- No intervention
- (no location specified)
Nov 3, 2022
Cutaneous Leishmaniasis, American Trial in Cali (Community based strategy to follow-up pactientes with Cutaneous Leishmaniasis)
Completed
- Cutaneous Leishmaniasis, American
- Community based strategy to follow-up pactientes with Cutaneous Leishmaniasis
-
Cali, Valle, ColombiaCorporación Centro Internacional de entrenamiento e Investigació
Sep 7, 2022
Primary Visceral Leishmaniasis Trial (LXE408, Placebo, AmBisome®)
Not yet recruiting
- Primary Visceral Leishmaniasis
- LXE408
- +2 more
- (no location specified)
Oct 20, 2022
Less Invasive Procedures for Visceral Leishmaniasis Treatment
Recruiting
- Visceral Leishmaniasis
- ELISA, LAMP, Cytokine Release Assay
-
Gondar, EthiopiaLeishmaniasis Research and Treatment Centre, Gondar University H
Jun 21, 2022
Cases of Cutaneous Leishmaniasis Treated With Miltefosine in
Not yet recruiting
- Cutaneous Leishmaniases
- +3 more
- Data collection
- Questionnaires
- (no location specified)
Aug 5, 2022
Mucosal Leishmaniasis Trial in Santa Cruz de la Sierra (Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal
Recruiting
- Mucosal Leishmaniasis
- Group 1: Miltefosine
- +2 more
-
Santa Cruz de la Sierra, SC, BoliviaHospital Dermatologico de Jorochito
Jun 14, 2022
Leishmaniasis Trial in Tübingen (Oleylphosphocholine)
Recruiting
- Leishmaniasis
-
Tübingen, GermanyInstitute for Tropical Medicine
Nov 8, 2023
Leishmaniasis Trial in Beer Sheva (Topical Amphotericin-B 0.4% liposomal gel)
Completed
- Leishmaniasis
- Topical Amphotericin-B 0.4% liposomal gel
-
Beer Sheva, IsraelSoroka University Medical Center
Mar 12, 2022
Status in Patients Before and After Treatment for Visceral
Recruiting
- Visceral Leishmaniasis
- Sodium stibogluconate / paramomycin
-
Nairobi, KenyaKEMRI
May 6, 2022
Leishmaniasis, Cutaneous Trial in Doka (ChAd63-KH, Placebo)
Active, not recruiting
- Leishmaniasis, Cutaneous
- ChAd63-KH
- Placebo
-
Doka, Gedarif, SudanInstitute of Tropical Medicine
Sep 29, 2022
Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa
Completed
- Leishmaniasis, Visceral
- Leishmania Ab Rapid Test (CTK, Biotech)
-
Gondar, Ethiopia
- +1 more
Jun 1, 2022
Leishmaniasis, Cutaneous Trial in Medellín (Arnica Tincture)
Not yet recruiting
- Leishmaniasis, Cutaneous
- Arnica Tincture
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Jun 4, 2022
Assess Usability of rK28 for Diagnosis of Visceral Leishmaniasis
Not yet recruiting
- Visceral Leishmaniasis
- rK28
-
Lodwar, Kenya
- +3 more
May 18, 2022
Leishmaniasis, Cutaneous Trial in Medellín (Experimental topical (Curaleish Topical))
Withdrawn
- Leishmaniasis, Cutaneous
- Experimental topical (Curaleish Topical)
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Jun 2, 2022
Leishmaniasis, Cutaneous Trial in Nice (Blood sampling)
Completed
- Leishmaniasis, Cutaneous
- Blood sampling
-
Nice, FranceNice Hospital
Mar 17, 2022
Cutaneous Leishmaniases Trial in Gondar (skin biopsy, venous blood sample (plasma, PBMC, WB), venous blood sample (HLA))
Recruiting
- Cutaneous Leishmaniases
- skin biopsy
- +3 more
-
Gondar, Amhara, EthiopiaUniversity of Gondar
Apr 11, 2022